|
Insider Trading: CV THERAPEUTICS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CV THERAPEUTICS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of CV THERAPEUTICS INC since year 2005. Table 2 shows the detailed insider transactions of CV THERAPEUTICS INC since 2005.
The reporting company's ticker symbol is CVTX.
The reporting company's CIK number is 921506.
The total value of stock buying since 2005 is $61,080.
The total value of stock sales is $1,391,875.
The total value of stock exercises is $1,311,430.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at CV THERAPEUTICS INC (CVTX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at CV THERAPEUTICS INC (CVTX) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for CV THERAPEUTICS INC (CVTX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 0 | 0 | 1,266 | 9,634 | 0 | 0 |
| 2008-06 | 0 | 0 | 839 | 6,653 | 0 | 0 |
| 2008-04 | 0 | 0 | 15,388 | 145,213 | 12,500 | 72,625 |
| 2008-03 | 0 | 0 | 3,213 | 23,519 | 11,345 | 0 |
| 2008-02 | 0 | 0 | 0 | 0 | 37,502 | 260,636 |
| 2008-01 | 0 | 0 | 26,245 | 230,808 | 10,837 | 92,500 |
| 2007-12 | 0 | 0 | 51,470 | 492,714 | 33,845 | 169,919 |
| 2007-11 | 0 | 0 | 2,497 | 25,444 | 0 | 0 |
| 2007-09 | 0 | 0 | 0 | 0 | 11,346 | 0 |
| 2007-08 | 0 | 0 | 10,000 | 100,900 | 10,000 | 90,000 |
| 2007-06 | 0 | 0 | 0 | 0 | 11,345 | 0 |
| 2007-03 | 0 | 0 | 0 | 0 | 36,345 | 222,500 |
| 2007-02 | 0 | 0 | 0 | 0 | 5,292 | 37,500 |
| 2007-01 | 0 | 0 | 7,000 | 97,510 | 81,469 | 0 |
| 2006-12 | 0 | 0 | 4,800 | 63,240 | 52,169 | 0 |
| 2006-08 | 0 | 0 | 0 | 0 | 26,800 | 235,750 |
| 2006-05 | 0 | 0 | 0 | 0 | 25,500 | 110,000 |
| 2006-03 | 0 | 0 | 8,000 | 196,240 | 8,000 | 20,000 |
| 2006-01 | 0 | 0 | 0 | 0 | 766 | 0 |
| 2005-03 | 3,000 | 61,080 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for CV THERAPEUTICS INC (CVTX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-08 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 1,266 | 7.61 | 9,634 |
| 2008-06-17 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 839 | 7.93 | 6,653 |
| 2008-04-30 | Suvari Tricia Borga (SVP, General Counsel & Sec) | Sale | 2,888 | 9.12 | 26,338 |
| 2008-04-25 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 12,500 | 9.51 | 118,875 |
| 2008-04-25 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 12,500 | 5.81 | 72,625 |
| 2008-03-31 | Suvari Tricia Borga (SVP, General Counsel & Sec) | Sale | 3,213 | 7.32 | 23,519 |
| 2008-03-24 | Lange Louis G (Chairman & CEO) | Option Exercise | 11,345 | .00 | 0 |
| 2008-02-26 | Stuart Lewis J (SVP COMMERCIAL OPERATIONS) | Option Exercise | 4,688 | 6.95 | 32,581 |
| 2008-02-26 | Suvari Tricia Borga (SVP, General Counsel & Sec) | Option Exercise | 4,688 | 6.95 | 32,581 |
| 2008-02-26 | Spiegelman Daniel K (SVP, CFO) | Option Exercise | 4,688 | 6.95 | 32,581 |
| 2008-02-26 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 4,688 | 6.95 | 32,581 |
| 2008-02-26 | Lange Louis G (Chairman & CEO) | Option Exercise | 18,750 | 6.95 | 130,312 |
| 2008-01-31 | Suvari Tricia Borga (SVP, General Counsel & Sec) | Sale | 16,245 | 8.36 | 135,808 |
| 2008-01-10 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 10,000 | 9.50 | 95,000 |
| 2008-01-10 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 10,000 | 9.25 | 92,500 |
| 2008-01-10 | Lange Louis G (Chairman & CEO) | Option Exercise | 837 | .00 | 0 |
| 2007-12-24 | Lange Louis G (Chairman & CEO) | Option Exercise | 11,345 | .00 | 0 |
| 2007-12-21 | Spiegelman Daniel K (SVP, CFO) | Sale | 6,000 | 10.00 | 60,000 |
| 2007-12-19 | Suvari Tricia Borga (SVP, General Counsel & Sec) | Sale | 11,019 | 9.20 | 101,374 |
| 2007-12-18 | Gutshall Thomas L (Director) | Sale | 7,500 | 9.01 | 67,560 |
| 2007-12-18 | Gutshall Thomas L (Director) | Option Exercise | 7,500 | 4.16 | 31,169 |
| 2007-12-11 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 18,951 | 9.68 | 183,540 |
| 2007-12-11 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 15,000 | 9.25 | 138,750 |
| 2007-12-10 | Spiegelman Daniel K (SVP, CFO) | Sale | 8,000 | 10.03 | 80,240 |
| 2007-11-09 | Stuart Lewis J (SVP COMMERCIAL OPERATIONS) | Sale | 2,497 | 10.19 | 25,444 |
| 2007-09-24 | Lange Louis G (Chairman & CEO) | Option Exercise | 11,346 | .00 | 0 |
| 2007-08-16 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Sale | 10,000 | 10.09 | 100,900 |
| 2007-08-16 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 10,000 | 9.00 | 90,000 |
| 2007-06-22 | Lange Louis G (Chairman & CEO) | Option Exercise | 11,345 | .00 | 0 |
| 2007-03-30 | Mcneil Barbara J (Director) | Option Exercise | 5,000 | 7.50 | 37,500 |
| 2007-03-22 | Lange Louis G (Chairman & CEO) | Option Exercise | 11,345 | .00 | 0 |
| 2007-03-08 | Lange Louis G (Chairman & CEO) | Option Exercise | 20,000 | 9.25 | 185,000 |
| 2007-02-22 | Lange Louis G (Chairman & CEO) | Option Exercise | 292 | .00 | 0 |
| 2007-02-21 | Gutshall Thomas L (Director) | Option Exercise | 5,000 | 7.50 | 37,500 |
| 2007-01-17 | Spiegelman Daniel K (SVP, CFO) | Sale | 7,000 | 13.93 | 97,510 |
| 2007-01-03 | Mccaleb David C (SVP Commercial Operations) | Option Exercise | 12,732 | .00 | 0 |
| 2007-01-03 | Suvari Tricia Borga (SVP, Gen Counsel, Asst Sec) | Option Exercise | 12,732 | .00 | 0 |
| 2007-01-03 | Spiegelman Daniel K (SVP, CFO) | Option Exercise | 12,732 | .00 | 0 |
| 2007-01-03 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 12,732 | .00 | 0 |
| 2007-01-03 | Lange Louis G (Chairman & CEO) | Option Exercise | 30,541 | .00 | 0 |
| 2006-12-22 | Lange Louis G (Chairman & CEO) | Option Exercise | 20,169 | .00 | 0 |
| 2006-12-19 | Mcneil Barbara J (Director) | Sale | 1,800 | 13.60 | 24,480 |
| 2006-12-12 | Spiegelman Daniel K (SVP, CFO) | Sale | 3,000 | 12.92 | 38,760 |
| 2006-12-05 | Mccaleb David C (SVP Commercial Operations) | Option Exercise | 5,000 | .00 | 0 |
| 2006-12-05 | Suvari Tricia Borga (SVP, Gen Counsel, Asst Sec) | Option Exercise | 5,000 | .00 | 0 |
| 2006-12-05 | Spiegelman Daniel K (SVP, CFO) | Option Exercise | 5,000 | .00 | 0 |
| 2006-12-05 | Blackburn Brent K (SVP, Drug Discovery & Dev) | Option Exercise | 5,000 | .00 | 0 |
| 2006-12-05 | Lange Louis G (Chairman & CEO) | Option Exercise | 12,000 | .00 | 0 |
| 2006-08-23 | Mcneil Barbara J (Director) | Option Exercise | 1,800 | 2.50 | 4,500 |
| 2006-08-23 | Lange Louis G (Chairman & CEO) | Option Exercise | 25,000 | 9.25 | 231,250 |
| 2006-05-17 | Mccaleb David C (SVP Commercial Operations) | Option Exercise | 10,000 | 7.12 | 71,250 |
| 2006-05-09 | Gutshall Thomas L (Director) | Option Exercise | 15,500 | 2.50 | 38,750 |
| 2006-03-07 | Mcneil Barbara J (Director) | Sale | 8,000 | 24.53 | 196,240 |
| 2006-03-07 | Mcneil Barbara J (Director) | Option Exercise | 8,000 | 2.50 | 20,000 |
| 2006-01-03 | Mccaleb David C (SVP Commercial Opera) | Option Exercise | 121 | .00 | 0 |
| 2006-01-03 | Suvari Tricia Borga (VP, Gen Counsel, Ass) | Option Exercise | 121 | .00 | 0 |
| 2006-01-03 | Spiegelman Daniel K (SVP, CFO) | Option Exercise | 121 | .00 | 0 |
| 2006-01-03 | Blackburn Brent K (SVP, Drug Discovery) | Option Exercise | 121 | .00 | 0 |
| 2006-01-03 | Lange Louis G (Chairman & CEO) | Option Exercise | 282 | .00 | 0 |
| 2005-03-14 | Shenk Thomas E (Director) | Purchase | 2,000 | 20.36 | 40,720 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of CV THERAPEUTICS INC (symbol CVTX,
CIK number 921506) see
the Securities and Exchange Commission (SEC) website.
|
|
